AA
Alok Awadhesh Kumar
About Alok Awadhesh Kumar
Data last updated:
Alok Awadhesh Kumar is a Director at J Duncan Healthcare Private Limited (since 2003), Managing Director at Lok-Beta Pharmaceuticals (India )Private Limited (since 2002) and Managing Director at Biosyntez Laboratories Private Limited (since 2011), and holds 1 more current directorship. The companies operate in Pharma and Life Sciences. The 2 current companies with reported revenue have a combined latest revenue of ₹143 Cr; the largest is J Duncan Healthcare Private Limited at ₹82.47 Cr (FY 2025). Earlier, Alok Awadhesh Kumar was a Director at Emprocell Clinical Research Private Limited (2006–2012) and Director at Bioveeta Laboratories Private Limited (2004–2010).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 J Duncan Healthcare Private Limited U24230MH2003PTC139202 | Director | 04 Nov 2003 | 2003 | ₹82.47 Cr (FY 2025) | Active |
PRIVATE_LIMITED.webp){kind=small} Lok-Beta Pharmaceuticals (India )Private Limited U24230MH2002PTC135577 | Managing Director | 18 Apr 2002 | 2002 | ₹60.20 Cr (FY 2024) | Active |
| Biosyntez Laboratories Private Limited U24100MH2011PTC214319 | Managing Director | 03 Mar 2011 | 2011 | Active | |
| Lokbeta Laboratories Private Limited U24239MH2006PTC165038 | Director | 03 Oct 2006 | 2006 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Emprocell Clinical Research Private Limited U24231MH2006PTC161334 | Director | 24 Apr 2006 | 2006 | ₹49.1 Lakh (FY 2020) | Active |
| Bioveeta Laboratories Private Limited U24230MH2004PTC147141 | Director | 24 Jun 2004 | 2004 | ₹1.29 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Alok Awadhesh Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hina Kiran | 00566172 | J Duncan Healthcare Private Limited , Lok-Beta Pharmaceuticals (India )Private Limited and 1 more | Whole-Time Director |
| Sudhanshu Kumar Singh | 03582994 | J Duncan Healthcare Private Limited , Lok-Beta Pharmaceuticals (India )Private Limited | Whole-Time Director |
| Ashish Kumar | 09781501 | Lok-Beta Pharmaceuticals (India )Private Limited | Director |
| Dhirendra Shankar | 03021791 | Biosyntez Laboratories Private Limited | Director |
| Satya Karm Punia | 00121027 | Biosyntez Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Alok Awadhesh Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alok Awadhesh Kumar
Alok Awadhesh Kumar currently holds 4 directorships: J Duncan Healthcare Private Limited (Director, since 04 Nov 2003, revenue ₹82.47 Cr (FY 2025)); Lok-Beta Pharmaceuticals (India )Private Limited (Managing Director, since 18 Apr 2002, revenue ₹60.20 Cr (FY 2024)); Biosyntez Laboratories Private Limited (Managing Director, since 03 Mar 2011); Lokbeta Laboratories Private Limited (Director, since 03 Oct 2006).
Alok Awadhesh Kumar was first appointed on 18 Apr 2002 as Managing Director at Lok-Beta Pharmaceuticals (India )Private Limited. The most recent appointment on record is 03 Mar 2011 at Biosyntez Laboratories Private Limited.
The 2 current companies of Alok Awadhesh Kumar that report revenue have a combined latest revenue of ₹143 Cr: J Duncan Healthcare Private Limited ₹82.47 Cr (FY 2025); Lok-Beta Pharmaceuticals (India )Private Limited ₹60.20 Cr (FY 2024).
Alok Awadhesh Kumar held 2 earlier board appointments: Emprocell Clinical Research Private Limited (Director, 24 Apr 2006 to 24 Oct 2012); Bioveeta Laboratories Private Limited (Director, 24 Jun 2004 to 28 Dec 2010).
The current boards of Alok Awadhesh Kumar's companies include Hina Kiran (J Duncan Healthcare Private Limited), Sudhanshu Kumar Singh (J Duncan Healthcare Private Limited), Ashish Kumar (Lok-Beta Pharmaceuticals (India )Private Limited), Dhirendra Shankar (Biosyntez Laboratories Private Limited), Satya Karm Punia (Biosyntez Laboratories Private Limited).